The World Health Organization (WHO) has approved the emergency use of China's corona vaccine 'Synovik'. Sino Week is already being held in Pakistan on a large scale.

According to the AFP news agency, this is the second vaccine developed by China, the use of which has been approved by the WHO.

The World Health Organization (WHO) said in a statement on Tuesday that the WHO had approved the emergency use of the synovic corona vaccine today. Vaccine purchasing countries, funding agencies, procurement agencies and communities are assured that Synovik meets global standards for preparation, efficacy and safety.

In Pakistan, the NCOC said on Monday that 5 million doses of the vaccine were arriving in June, including China's Synovik. Last month, the World Health Organization approved the use of China's first corona vaccine, Synoform.

There are currently four corona vaccines being used around the world. The WHO had earlier approved the emergency use of Pfizer and Biotech's Corona vaccine, as well as Moderna, Johnson & Johnson and AstraZeneca. AstraZeneca is developed separately in India, South Korea and the European Union and is considered by the World Health Organization to be three different vaccines. After being approved by the World Health Organization and listed as a safe vaccine, countries around the world are contacting to buy the vaccine to protect their citizens from the epidemic.

Approved vaccines open the door to joining the Global Vaccine Vaccine Sharing Scheme. The scheme aims to make it possible for citizens of countries around the world, especially in developing countries, to receive timely vaccinations against coronavirus. Some of Pfizer's doses are currently being supplied to different countries through the scheme, along with the Strazina vaccine. Mariangela Simao, assistant director of the World Health Organization, said the world desperately needed a number of corona vaccines to address the widespread inequality of access. "We urge vaccine makers to participate in the vaccine scheme and contribute to the global epidemic."